Lecture 1: Intro, Overview Flashcards

1
Q

Prescribing Authority: Considerations

A

Will professional standards improve services provided?

Does an integrated approach lead to better outcome?

Does it increase cost-effectiveness?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The case FOR prescribing authority

A

Logical extension as a healthcare provider

Serves communities where psychiatrists aren’t available

Primary care physicians receive very limited training in psychopharmacology and mental health, yet they are the most common prescribers of psychotropic meds

Primary care physicians are only able to spend limited time with patients [Whereas a psychologist meets on a regular basis is likely to provide a higher quality of care]

Many GPs are already consulting psychologists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The case AGAINST prescribing authority

A

Main argument – negative effect on professional identity

It will “medicalize” the field

Psychologists lack formal medical training

*financially and politically motivated

  • move away from psychotherapy
    e. g. possible to triple daiily # of patients
    • make more money by just prescribing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Serper: prescribing authority should not be main focus

A

“Psychiatrists’ kingdom” = hospital and prescription privileges

Instead of prescribing authority, energy should be spent fighting for hospital privileges

Once someone is inpatient, it’s completely up to hospital staff to grant privileges to psychologists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ethical obligation of all psychologists

A

Assessment and treatment services in a competent manner

This includes understanding of medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Beneficence

A

We are obligated to provide the most effective treatment

Non-malfeasance

Fidelity

Autonomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Collaborative Care [aka Integrated Approach]

A

Process and evolution of treatment of patient
e.g. medication in conjunction with psychotherapy

Biopsychosocial model:
*impact of medication on the patients, families, home, workplace

*collaborate with those who extend beyond your knowledge base to provide the best service possible

Each member of team does not need to know everything, since they are not the sole provider of treatment

*you don’t need to administer meds to engage in collaborative care
(though often pdoc don’t / won’t contact you)

**This is NOT consultation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

APA 3 levels of training

A

*Important foror psychologists to have knowledge of pharmacology, regardless of whether or not we get prescription privileges

  1. Basic pharmacology education
  2. Psychodiagnosis
  3. Extensive clinical supervision

We are expected to know the conditions in which clients should be referred for psychiatric treatment
• Level 1 training is a minimal requirement to meet this standard level of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Basic pharmacology education

A

To competently provide assessment and treatment services to the patient:

Basic pharmacology

Drug biodisposition

Therapeutic uses of psychopharmacological agents

Drug behavior interactions

Methods of clinical research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Psychodiagnosis

A

Medication selection and administration based on the diagnosis

Basically to know which meds would and would not be good for patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Extensive supervised clinical supervision

A

Working with patients under supervision AND prescribing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Collaborative-Care vs Consultation Model

A

Collaborative-care model

  • A process
  • Addresses gaps in time

Consultation model
*Single event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Osheroff v Chestnut Lodge

A

Pharmacological treatment was not considered, even though ethically obligated
*Lawsuit conclusion: need to provide alternatives or options of treatment

If patient refuses phramacological treatment, doctor must discuss fears and concerns:
document patient’s refusal

During consent process, need to notify clients of medical options and that we cannot provide them with this option

MS: you have to bring it up within the first session:
“if you want to work with me, this is what I do”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

“Never presume the presence or absence of anything”

A

*All medication will have side effects – many appear like psychiatric conditions

Other substances may cause symptoms that mimic disorders
o e.g. interactions, caffeine withdrawal, alcohol withdrawal, melatonin

Always ask 
o	have you stopped anything recently?
o	substance use history
o	past medications
*duration
*frequency
*amount
*tx effects
*side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Underlying causes: Too few neurotransmitters

A

Parkinson’s = decreased dopamine receptors due to cell death

Alzheimer’s = decreased acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Underlying causes: Too many neurotransmitters

A

Schizophrenia = increased dopamine in frontal lobes for positive symptoms

17
Q

Underlying causes: Excessive activation of specific neurons

A

Leads to cell death: “exitotoxicity”

Epilepsy
*treated with GABA agonist in order to inhibit neural firing

18
Q

Underlying causes: Faulty wiring

A

“Cross-talk,” poor pruning

Linked with schizophrenia, autism, and intellectual disabilities

19
Q

General pharmacological strategies

A

Assesment /Indication: Establish dx, target sx,

Choice of agent and dosage

Informed consent

Implement a monitoring program

20
Q

General Psychopharm strategies: Choice of agent and dosage

A

Select an agent with an acceptable side effect profile

Use the lowest effective dose

Factor in the delayed response for many psych meds and drug-drug interactions.

21
Q

General Psychopharm strategies: Informed Consent

A

Patient should understand the benefits and risks of the medication

Document discussion including pt understanding and agreement.

In fertile women, make sure to document teratogenicity discussion

22
Q

General Psychopharm strategies: Monitoring

A

Track and document:
*compliance

  • side effects
  • target symptom response
  • blood levels and blood tests as appropriate